Virtual RPC Meeting: Taking a Look at Psychedelic Therapies
Compelling new evidence is emerging on the therapeutic use of psychedelics as a treatment for mental health conditions, such as depression, anxiety, and post-traumatic stress. Please join us for an exciting virtual Regional Policy Council meeting as we hear from experts about new research and practices in the field. This virtual meeting was held on Oct. 24 from 1:30 - 3 p.m. EST.
Virtual RPC Meeting
Welcome Remarks
- Debbie Plotnick
An Examination of the Potential Advantages and Pitfalls of Psychedelics
- Dr. Rakesh Jain, MD, MPH, co-founder of Jain Uplift
- Dr. Saundra Jain, MA, PsyD, LPC, co-founder of Jain Uplift
Translation of Tradition Through Psychedelic Medicine
- Kathryn Walker, APRN, CRNA, PMHNPS, founder of Revitalist - one of the largest publicly listed, ketamine-focused clinic operations in the United States with locations across 8 states
Information about MHASCK's Esketamine clinic
- Mary Jones, LCMFT, LCAC, President and CEO of Mental Health Association of South-Central Kansas (MHASCK)
Translating Science to Advance Human Potential
- Jazz Glastra, Director of Program Operations of BrainFutures, a subsidiary of the Mental Health Association of Maryland